Umeclidinium + Vilanterol Trifenatate

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandDoseManufacturer
umeclidinium bromide and vilanterol trifenatateUS0.0625 mg / 0.025 mgGlaxoSmithKline LLC
Anoro Ellipta 55/22 mcg inhalation PowderSGTW62.5 mcg/dose / 25 mcg/doseGLAXOSMITHKLINE PTE LTD
Umeclidinium and Vilanterol ElliptaUS0.0625 mg / 0.025 mgPrasco Laboratories
vilanterol trifenatate + umeclidinium bromideAU——
安肺樂易利達 55/22 mcg 乾粉吸入劑TW—荷商葛蘭素史克藥廠股份有限公司台灣分公司
肺樂喜易利達92/55/22 mcg乾粉吸入劑TW—荷商葛蘭素史克藥廠股份有限公司台灣分公司
Trelegy Ellipta 92/55/22 mcg Inhalation PowderTW—荷商葛蘭素史克藥廠股份有限公司台灣分公司
肺樂喜易利達184/55/22 mcg 乾粉吸入劑TW—荷商葛蘭素史克藥廠股份有限公司台灣分公司
Trelegy Ellipta 184/55/22 mcg Inhalation PowderTW—荷商葛蘭素史克藥廠股份有限公司台灣分公司
ANORO ELLIPTA 62.5/25 umeclidinium (as bromide)/vilanterol (as trifenatate) 62.5 microgram/25 microgram powder for inhalationAU74.2 microgram / 40 microgramGlaxoSmithKline Australia Pty Ltd

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.